Influence of Environmental Conditions on In Vitro Fertilization (IVF) Attempts and Induced Pregnancies (MeteoFIV)

November 17, 2017 updated by: Assistance Publique - Hôpitaux de Paris

The main purpose of the study is to assess the impact of environmental conditions on live-birth rates after intraconjugal IVF.

The second purposes are

  • to assess the impact on pregnancies (prematurity, preeclampsia);
  • to assess the impact on newborn's health (stunted growth);
  • to evaluate the consistency of results observed between assisted pregnancies and spontaneous pregnancies.

Study Overview

Detailed Description

This multicenter epidemiological study aims to analyze the individual standardized clinical records, collected prospectively since 2008 in the medically assisted procreation centers (MAP).

These individual data will be mapped to the environmental data (meteorological and air quality), recorded in the area of residence of the mother at the time of conception and pregnancy, as well as to the socio-economic data.

Choice of centers:

  • The study will be proposed to the 106 private or public centers in metropolitan France who are authorized for MAP procedures such as IVF and ICSI.
  • Only the centers who perform more than 200 oocyte retrievals per year will be selected to participate in the study.

More than 80% of attempts performed by the selected centers should be available (without missing data) on the induced pregnancies and their outcome (minimum data set for each case: age of man and woman, cause of infertility, technique used, sperm collection method (ejaculation, surgical sperm retrieval techniques), total number of embryos obtained, clinical pregnancy or not, term of pregnancy, weight and height of the child at birth).

Study Type

Observational

Enrollment (Anticipated)

24000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hauts-de-seine
      • Boulogne-Billancourt, Hauts-de-seine, France, 92100
        • Recruiting
        • Alain BEAUCHET
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study focuses on intraconjugal IVF attempts (conventional IVF, microinjection intra-cytoplasmic sperm injection (ICSI) and frozen embryo transfers) realised for MAP procedures in metropolitan France, in the period of 01/01/2008 to 12/31/2012 (5 years).

Description

Inclusion Criteria:

  • Intraconjugal IVF and ICSI
  • Transfers of frozen embryos after intraconjugal IVF or ICSI

Exclusion Criteria:

  • IVF and ICSI with sperm donation
  • IVF and ICSI with egg donation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Live birth rate
Time Frame: 1 year
Live birth rate after intraconjugal IVF (IVF and ICSI) by oocyte retrieval and by embryo transfer.
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fertilization rate
Time Frame: 1 year
Rate of fertilization (IVF and ICSI), rate of good quality embryos, rate of blastoformation (if prolonged culture), rate of embryo freezing.
1 year
Rates of clinical pregnancy
Time Frame: 1 year
Rates of assisted pregnancy, rate of spontaneous miscarriage, rate of medical termination of pregnancy, rate of pathology of pregnancy (pre-eclampsia, gestational diabetes, placenta praevia, signs of preterm labor with hospitalization).
1 year
Fetal growth restriction rate
Time Frame: 1 year
Fetal growth restriction rate, biometrics of child at birth (height, weight, head circumference, Body Mass Index), preterm birth rate, transfer rate to intensive care units.
1 year
Effect sizes and periods of susceptibility to environmental conditions
Time Frame: 5 years
Effect sizes and periods of susceptibility to environmental conditions among assisted pregnancies and spontaneous pregnancies.
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Philippe AEGERTER, MD, PhD, Hôpital Ambroise Paré, AP-HP
  • Study Chair: Alain BEAUCHET, MD, Hôpital Ambroise Paré, AP-HP
  • Study Director: Rachel LEVY, MD, PhD, Hôpital Jean Verdier, AP-HP

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2015

Primary Completion (Anticipated)

January 1, 2018

Study Completion (Anticipated)

January 1, 2018

Study Registration Dates

First Submitted

September 8, 2014

First Submitted That Met QC Criteria

September 8, 2014

First Posted (Estimate)

September 11, 2014

Study Record Updates

Last Update Posted (Actual)

November 20, 2017

Last Update Submitted That Met QC Criteria

November 17, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AOR13130

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on In Vitro Fertilisation

Subscribe